Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
Clinical trial NCT04593784 · TERMINATED
Trial details
- NCT number
- NCT04593784
- Sponsor
- AMAG Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2023-08-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.